toxins Article Aspergillus flavus Growth Inhibition and Aflatoxin B1 Decontamination by Streptomyces Isolates and Their Metabolites Ixchel Campos-Avelar 1,* , Alexandre Colas de la Noue 1,*, Noël Durand 1,2 , Guillaume Cazals 3, Véronique Martinez 1, Caroline Strub 1 , Angélique Fontana 1 and Sabine Schorr-Galindo 1 1 UMR Qualisud, University of Montpellier, 34095 Montpellier, France;
[email protected] (N.D.);
[email protected] (V.M.);
[email protected] (C.S.);
[email protected] (A.F.);
[email protected] (S.S.-G.) 2 CIRAD, UMR Qualisud, 34398 Montpellier, France 3 IBMMUMR5247, University of Montpellier, CNRS, ENSCM, Place Eugène Bataillon, 34095 Montpellier, France;
[email protected] * Correspondence:
[email protected] (I.C.-A.);
[email protected] (A.C.d.l.N.) Abstract: Aflatoxin B1 is a potent carcinogen produced by Aspergillus flavus, mainly during grain storage. As pre-harvest methods are insufficient to avoid mycotoxin presence during storage, diverse curative techniques are being investigated for the inhibition of fungal growth and aflatoxin detoxification. Streptomyces spp. represent an alternative as they are a promising source of detoxifying enzymes. Fifty-nine Streptomyces isolates and a Streptomyces griseoviridis strain from the commercial product Mycostop®, evaluated against Penicillium verrucosum and ochratoxin A during previous work, were screened for their ability to inhibit Aspergillus flavus growth and decrease the aflatoxin Citation: Campos-Avelar, I.; Colas amount. The activities of bacterial cells and cell-free extracts (CFEs) from liquid cultures were also de la Noue, A.; Durand, N.; Cazals, evaluated. Fifty-eight isolates were able to inhibit fungal growth during dual culture assays, with a G.; Martinez, V.; Strub, C.; Fontana, A.; Schorr-Galindo, S.